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A B S T R A C T
Green-plant membranes, thylakoids, have previously been found to increase postprandial release of the
satiety hormone GLP-1, implicated in reward signaling. The purpose of this study was to investigate how
treatment with a single dose of thylakoids before breakfast affects homeostatic as well as hedonic hunger,
measured as wanting and liking for palatable food (VAS). We also examined whether treatment effects
were correlated to scores for eating behavior. Compared to placebo, intake of thylakoids signiﬁcantly reduced
hunger (21% reduction, p < 0.05), increased satiety (14% increase, p < 0.01), reduced cravings for all snacks
and sweets during the day (36% reduction, p < 0.05), as well as cravings for salty (30%, p < 0.01); sweet
(38%, p < 0.001); and sweet-and-fat (36%, p < 0.05) snacks, respectively, and decreased subjective liking
for sweet (28% reduction, p < 0.01). The treatment effects on wanting all snacks, sweet-and-fat snacks
in particular, were positively correlated to higher emotional eating scores (p < 0.01). The treatment effect
of thylakoids on scores for wanting and liking were correlated to a reduced intake by treatment (p < 0.01
respectively), even though food intake was not affected signiﬁcantly. In conclusion, thylakoids may be
used as a food supplement to reduce homeostatic and hedonic hunger, associated with overeating and
obesity. Individuals scoring higher for emotional eating behavior may have enhanced treatment effect
on cravings for palatable food.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Introduction
Eating is a great pleasure in life. However, snacking between
meals, as well as ingestion of snacks and fast foods, has been as-
sociated with weight gain and obesity in all age groups (Garber &
Lustig, 2011; Mesas, Muñoz Pareja, López García, & Rodríguez
Artalejo, 2012). Since life in general has become more sedentary,
overeating of palatable, energy dense foods causes a positive
energy balance (Blundell & Cooling, 2000; Yeomans, Blundell,
& Leshem, 2004) which may result in an increasing incidence
of overweight and obesity worldwide (Blundell & Macdiarmid,
1997; Erlanson-Albertsson, 2005; Finkelstein et al., 2012;
WHO, 2015).
The reason for overeating is that hunger has a homeostatic com-
ponent but also a hedonic part, driven by the rewarding values of
food (Berridge, 2009; Berthoud, 2011). Hedonic hunger favors
energy-dense palatable food, rich in sugar and fat, for example
snacks, pastries, desserts, baked confectionery and sweets – foods
typically ingested in between meals and preferred by women
(Drewnowski, 1997; Montmayeur, le Coutre, Drewnowski, &
Almiron-Roig, 2010). While homeostatic eating is due to energy de-
ﬁciency, hedonic eating is triggered by the anticipation of pleasure,
regardless of energy status. The hedonic hunger is constituted by
two components, wanting and liking (Finlayson, King, & Blundell,
2007; Mela, 2006). Wanting represents the anticipation phase, the
motivation to eat a food item, and is triggered by cues. Liking is the
hedonic reaction of the pleasure experienced through a reward-
ing orosensory stimuli.
Abbreviations: BMC, Biomedical Centre; E%, energy percentage; TFEQR18-V2, The
Three Factor Eating Questionnaire, Revised 18-item, Version 2; VAS, visual analog
scale.
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Even though the homeostatic and non-homeostatic pathways are
separate, they affect each other (Finlayson et al., 2007). When the
reward circuit interacts with the appetite-controlling neurons in the
hypothalamus, this can result in up-regulated expression of hunger
signals and blunting of satiety signals (Erlanson-Albertsson, 2005).
Therefore, ingestion of palatable food, instead of terminating food
intake, leads to a maintained drive to eat, with continued eating due
to reward rather than energy deﬁcit (Finlayson et al., 2007). Over-
eating then becomes a possibility (Berthoud, 2006; Blundell &
Macdiarmid, 1997). It has been suggested that individuals who are
obese, dieting and/or under stress are more susceptible to hedonic
eating (Garber & Lustig, 2011). In emotional eaters, who tend to
develop overweight due to over-eating, food craving and consump-
tion of food rich in carbohydrates and fat increase in response to
stressors or negative affect (Cappelleri, Bushmakin, & Gerber, 2009;
Raspopow, Abizaid, Matheson, & Anisman, 2010.
Obviously, there is a need to prevent overeating to avoid weight
gain. One way is to attenuate the hedonic drive in those who ex-
perience increased cravings for palatable food.
Green-plant membranes, thylakoids, have been shown to reduce
feelings of hunger as well as cravings for palatable food in human
participants, during diet intervention and simultaneous weight loss
in overweight women (Montelius et al., 2014; Stenblom et al., 2013,
2014). We found that these effects are connected to an altered se-
cretion of appetite regulating hormones, including ghrelin,
cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1), in
rodents, pigs and humans (Köhnke, Lindbo et al., 2009; Köhnke,
Lindqvist et al., 2009; Montelius, Osman et al., 2013; Montelius,
Szwiec et al., 2013; Montelius et al., 2014). Based on these ﬁnd-
ings of suppressed hedonic hunger and increased levels of GLP-1,
wewere interested to deepen our knowledge of these effects on over-
weight middle-aged women in a similar group of participants but
in a non-laboratory setting. In addition, since emotional eating is
associated with overeating of snacks, we were interested to inves-
tigate any potential correlation between scores for eating behavior
and the treatment effect of thylakoids.
Aim/primary objectives
The aim of this study was to investigate in a non-laboratory
setting 1) how treatment with a thylakoid-rich spinach extract (from
now on called thylakoids), served as ameal supplement before break-
fast, affects subjective ratings of wanting and liking for snacks and
sweets, as well as hunger and satiety, using visual analog scales (VAS),
2) to examine how thylakoid treatment affects intake of palatable
food from an ad libitum buffet of the same sweets and snacks the
participants rated their cravings for during the day, and 3) to in-
vestigate if the treatment effect of thylakoids is associatedwith scores
for eating behavior.
Materials and methods
Participants
Thirty-two women were recruited through local advertising. The
volunteers were assessed for eligibility through a screening pro-
cedure including questionnaires evaluating general health and
subjective liking for different food products. During the screening
process, 6 women were excluded and 26 women included in the
study. Inclusion criteria were: women ages 40–70, normal weight
or overweight. Exclusion criteria were: Diabetes, illnesses affect-
ing appetite, food allergies or intolerance to food served in the study,
or dieting during the last 3 months. Twenty-two participants com-
pleted the study and were included in the ﬁnal analysis (Table 1).
Eating behavior questionnaire
Prior to the trial days, the participants ﬁlled out the Three-
Factor Eating Questionnaire Revised 18-item, Version 2 (TFEQ-
R18V2) (Cappelleri et al., 2009). This is a revised version of the
original Three-Factor Eating Questionnaire (TFEQ), a self-assessment
scale used in studies of eating behavior. TFEQ-R18V2 contains 18
questions to measure three types of eating behavior: emotional
eating, uncontrolled eating and cognitive restraint. Previous results
from a large diverse sample of non-obese, as well as obese partici-
pants, showed a good reliability, and the domains were reported
to be robust and stable (Cappelleri et al., 2009).
Study design
The study was a randomized, placebo-controlled, double blind,
single-centered meal intervention study with a cross over design,
conducted at the Biomedical Centre (BMC) at Lund University,
Sweden. Each participant was tested on two days, separated by a
wash out period of at least 1 week, receiving a 5 g supplement of
thylakoids (Appethyl, Greenleaf Medical AB, Stockholm, Sweden)
on one day and placebo on the other. The allocation to treatment
or placebo was randomized and balanced between test days. The
participants were not able to identify which drink contained the
active component.
Participants arrived in the morning, fasted from 22:00 the night
before (schedule, Table 2).
No alcohol or intense physical activity was allowed the days
before or during test days.
Before breakfast, the participants ﬁlled out a questionnaire con-
structed as Visual Analog Scales (VAS) (Flint, Raben, Blundell, &
Astrup, 2000) with questions regarding hunger, satiety and wanting
for speciﬁc food products (Table 3). The questionnaire was con-
structed as a booklet with written instructions on the ﬁrst page. All
questions were followed by a 100-mmhorizontal line, on which sub-
jects marked their response. The line was anchored at each end,
expressing the minimum value on the left: “Not at all”, and the
Table 1
Baseline characteristics.
Median Interquartile range Range (min–max)
Age (years) (n = 22) 54.5 47.0–59.5 40–66
BMI (kg/m2) (n = 22) 25.3 24.5–29.4 22.4–36.2
Body fat (%)a (n = 21) 37.2 31.5–40.4 26.9–47.1
a Body composition analyzer TANITA-BC 418 MA (Amsterdam, The Nether-
lands). One participant was excluded from this analysis due to failure of the body
composition analyzer.
Table 2
Test day schedule, days 1 and 2.
07:30 Participants arrived at BMC
07:45 VAS Baseline; Time point 0
08:00 Blueberry drink, with/without 5 g thylakoids
(treatment/placebo)
Breakfast, including coffee/tea
08:15 VAS Time point 15 min
09:00 VAS Time point 60 min
10:00 VAS Time point 120 min
11:00 VAS Time point 180 min
12:00 VAS Time point 240 min
12:45 VAS Time point 285 min
13:00 Lunch Time point 300 min
13:20 VAS Time point 320 min
14:00 VAS Time point 360 min
15:00 VAS Time point 420 min
16:00 Snack buffet served. VAS Time point 480 min
16:45 VAS after snack buffet Time point 525 min
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maximum value on the right: “Extremely”. Subsequently, a blue-
berry drink, with or without supplementation of thylakoids, was
served followed by a standardized high carbohydrate Swedish break-
fast. The VAS-questionnaire was ﬁlled out every hour as well as
before and after lunch and the ad libitum snack buffet, served at 13:00
and 16:00 respectively.
Between breakfast and lunch, participants left the premises for
work or free activities, and were reminded to ﬁll out the VAS-
questionnaires every hour via text messages. After lunch, the
participants stayed in their allocated seats, sitting side by side with
cardboard dividers between them, all facing a window. They were
allowed to read or work on laptops until 16:00when the snack buffet
was served at the table on individual trays. A leaﬂet containing in-
formation about the products served accompanied the buffet
describing the freshness of the foods. It included names of manu-
facturers and pictures of the packaging. The same pictures were used
for the VAS-questionnaire. Before starting to eat from the snack buffet
in front of them, the participants ﬁlled out the VAS-questionnaire
once more. Then they were allowed to eat freely from the prod-
ucts on their trays, encouraged to follow their urges and ask for more
should they run out. They were occupied by the snack buffet for
45 min, not doing anything else during this time. Afterwards, they
ﬁlled out the VAS-questionnaire again, this time including ques-
tions regarding how much they liked the products they tasted that
particular day, to enable evaluation of the rewarding properties of
the items (Table 3). On the last page the participants were asked
about adverse effects: “Have you experienced any new symptom
or discomfort during the day, for example headache, rash, or nausea?”
Power and sample size
The number of participants required to achieve a power of 0.8
in this cross-over study was calculated using data from an earlier
study (Stenblom et al., 2013). Based on these calculations, 15 par-
ticipants were needed to detect a 10 mm difference in VAS-ratings
of hunger. This number of participants is also suﬃcient for detect-
ing differences in ratings for wanting palatable food (Flint et al.,
2000). According to literature, 17 participants should be suﬃcient
for detecting a difference in food intake of 500 kJ/120 kcal (Gregersen
et al., 2008).
Ethics
The study was approved by the Ethics Committee for Human
Studies in Lund (2006/361). The trial was conducted in accor-
dance with the Declaration of Helsinki. All participants gave written
informed consent before the study began. The participants did not
receive any monetary compensation.
Thylakoids
All leafy green vegetables contain thylakoids. Five grams of ex-
tracted thylakoids is equivalent to 100 g of spinach. However, humans
cannot utilize thylakoids in unprocessed vegetables, since the thyla-
koids are stacked inside non-digestible plant cell walls. Therefore,
the only realistic way to achieve a dose compared to the one used
in this study is to consume thylakoids as a supplement.
The thylakoids used in the present study were prepared from
baby spinach leaves using the pH-method as previously described
(Emek et al., 2010), followed by drum drying. One hundred grams
of thylakoids contain 185 kcal, 26.1 g protein, 7.24 g fat, 48.7 g car-
bohydrate (including non-soluble and soluble ﬁbers), 27.9mg lutein,
730 μg zeaxanthin, 3.45mg beta carotene, 21 μg vitamin A, 1330 μg
vitamin K1, 6.07 mg vitamin E and 166 μg folic acid.
Based on a previous dose–response study, a single dose of 5 g
thylakoids was used in this study (Stenblom et al., 2013). The thyla-
koids were served in a cold blueberry drink, mixed with 2.5 g
rapeseed oil (Zeta, Di Luca & Di Luca AB, Stockholm, Sweden) and
92.5 g blueberry soup (Ekströms original, Procordia Food AB, Eslöv,
Sweden), served immediately before breakfast on treatment test days.
On control test days, the participants were served a placebo drink,
which consisted of 2.5 g rapeseed oil mixed with 92.5 g blueberry
soup. The blueberry drinks contained 73 kcal with thylakoids and
64 kcal without.
Meals
Breakfast on both test days was a standardized Swedish high car-
bohydrate breakfast with yogurt andmuesli, one slice of white bread
with butter, cheese and sweet pepper, coffee or tea. Total energy
content was 509 kcal. The energy distribution was 31.2 percent of
total energy (E%) fat, 15.4 E% protein and 53.4 E% carbohydrates.
Sugars constituted 22.6 E%. The lunch served on both test days was
a slice of thick crust pizza, made from sourdough, with tomato sauce,
ham, onion, mushrooms and cheese, served with boiled broccoli and
tap water. Coffee or tea following lunch was optional, but subjects
were required to have the same on both test days. Energy distri-
bution of the lunch was 45.9 E% carbohydrates, 32.5 E% fat and 21.6
E% protein. Total energy content was 480 kcal. In addition, partici-
pants were allowed one cup of coffee/tea, without sugar or
sweetener, between breakfast and lunch, and one cup of coffee/
tea after lunch. Calculations of energy distribution were made using
Dietist Net Pro (Kost och Näringsdata AB, Bromma, Sweden).
Snack buffet
A product questionnaire was constructed for this study as a tool
for choosing well-suited products to measure cravings and snack
intake in a Swedish population. It contained speciﬁc questions about
snacks of the most popular brands in Sweden: potato chips, nuts,
chocolate, sweets, baked confectionery, buns, fruit juice and soft
drinks. Questions were asked about how often the responders con-
sumed the palatable foods, how much they liked the products on
a nine point hedonic scale and which product in each category they
Table 3
VAS-questions (translated from Swedish).
Hunger and satiety
1. How hungry are you right now?
2. How satiated are you right now?
Wanting
3. How much do you want potato chips right now?
4. How much do you want salted assorted nuts right now?
5. How much do you want milk chocolate right now?
6. How much do you want dark chocolate right now?
7. How much do you want sweets right now?
8. How much do you want “Dumlekola” right now?
9. How much do you want “Ahlgrens bilar” right now?
10. How much do you want “Gott & Blandat” right now?
11. How much do you want “en chokladboll” right now?
12. How much do you want a cinnamon bun right now?
13. How much do you want some orange juice right now?
Liking
1. How much did you like the potato chips?
2. How much did you like the salted assorted nuts?
3. How much did you like the milk chocolate?
4. How much did you like the dark chocolate?
5. How much did you like the “Dumlekola”?
6. How much did you like the “Ahlgrens bilar”?
7. How much did you like the “Gott & Blandat”?
8. How much did you like the “chokladboll”?
9. How much did you like the cinnamon bun?
10. How much did you like the orange juice?
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preferred. Based on the responses, a range of snacks, sweets and
confectionery was chosen for the snack buffet (Table 4). These prod-
ucts were grouped in three different categories: salty, sweet, and
sweet-and-fat snacks. Snacks with salty taste included potato chips
and salted assorted nuts; products with sweet taste, containing sugar,
included two different kinds of sweets and orange juice; products
with sweet taste containing both sugar and fat were: milk
chocolate, dark chocolate, chocolate covered toffee, chocolate pastry,
and cinnamon bun. Each participant received a tray with the prod-
ucts served in separate containers, weighed before and after
consumption. The amount of sweets and snacks was large enough
to allow the participants to consume as much as they liked while
preventing all of the food from being consumed. Coffee, tea andwater
were served with the snacks in a limited amount. The drinks were
optional, but the participants had to have the same drinks on both
test days.
Statistics
All statistical analyses were done using the Prism version 6, sta-
tistical software (GraphPad Software, Inc, San Diego, CA, USA). Normal
distribution of the paired parameters and the calculated differ-
ences between treatment and control conditions was computed by
d’Agostino and Pearson omnibus normality test, veriﬁed by boxplot
and histogram analysis and comparison between mean and median
values. Variations in VAS-ratings over time were analyzed with a
two-way repeatedmeasures (RM) ANOVA in order to test time, treat-
ment, and time by treatment interaction. Analyses of VAS-ratings
at individual time points as well as differences in total area under
the curve (tAUC) for VAS-ratings, food intake and ratings of liking
were performed usingWilcoxonmatched-pairs signed rank test. Re-
ported p-values in text and ﬁgure legends were analyzed with
Wilcoxon matched-pairs signed rank test if not otherwise stated.
Treatment effect of thylakoids on feelings of hunger, satiety and
urge for speciﬁc food products and liking respectively was calcu-
lated by subtracting VAS-ratings for treatment day from control day
values, except for satiety, which was calculated the opposite way.
Treatment effect on food intakewas calculated as difference in caloric
intake between control and treatment days. Calculating delta values
for the treatment effects was required to account for paired obser-
vations. These delta values were then correlated to eating behavior
scores, as measured by the TFEQR18-V2 questionnaire, divided into
the three domains: emotional eating, uncontrolled eating and cog-
nitive restraint. Correlations were also calculated between eating
behavior scores, BMI and body fat percentage (Table 1) as well as
between treatment effects on wanting and liking respectively versus
food intake. All correlations were computed by Pearson correla-
tion coeﬃcient. Correlation coeﬃcients (r), and coeﬃcients of
determination, (R2), equal to and above 0.3 were considered fairly
strong and have been included in the manuscript. In both ﬁgures
and text, data are expressed asmean +/− SEM if not otherwise stated.
p-values <0.05 were considered statistically signiﬁcant, and p-values
<0.10 of interest.
Results
VAS-ratings on hunger and satiety
Treatment with thylakoids reduced subjective ratings of hunger
compared to control throughout the day (F (1,21) = 6.237, p < 0.05,
Fig. 1A). tAUC for hunger decreased by 21% between control and
treated conditions (p < 0.05, Fig. 1B). The difference in hunger ratings
between control and treatment was most pronounced prior to lunch
and before the snack buffet, reaching highest signiﬁcance at time
points 285 min and 480 min after beginning of breakfast (Fig. 1A).
Treatment with thylakoids also increased ratings of satiety com-
pared to control (Fig. 1C, D). Satiety-scores were generally higher
during the whole day in the treated condition (F (1,21) = 8.745,
p < 0.01, Fig. 1C), tAUC for satiety being increased by 14% follow-
ing treatment (p < 0.01, Fig. 1D). Signiﬁcant differences in satiety
between control and treatment groups were observed at 60 and
120min, as well as immediately before the snack buffet at time point
480 min (Fig. 1C).
VAS-ratings on wanting palatable foods
Treatment with thylakoids decreased subjective feelings of
wanting all kinds of palatable food compared to control (Fig. 2). VAS-
ratings were consistently lower during the treatment test day for
all categories of snacks (salty, sweet and sweet-and-fat) as well as
total wanting for all snacks.
Ratings for wanting salty snacks in the treated and control con-
ditions are presented in Fig. 2A. Treatment with thylakoids reduced
cravings for salty snacks continuously during the day (F (1,21) = 6.110,
p < 0.05). tAUC decreased by 30% between control and treated con-
ditions (p < 0.01, Fig. 2B). Speciﬁcally, the urge for salty snacks was
lower in the treated group at time points 60, 120 and 360 minutes
compared to the control (Fig. 2A).
Effect of treatment on ratings for wanting sweet snacks is pre-
sented in Fig. 2C (F (1,21) = 8.412, p < 0.01). Wanting for sweet
Table 4
Components of the snack buffet, energy content per 100 g.
Products Calories (kJ/kcal) Protein (g/E%) Fat (g/E%) Carbohydrate (g/E%) Sugar (g/E%) Salt (g)
Salty
Potato chips “Sourcream & Onion” (Estrella, Sweden) 2200/525 6.0/4.6 32.5/56.4 50.5/39 3.6/2.8 1.7
Assorted nuts “Vår klassiska nötmix” (OLW, Sweden) 2450/590 25.0/16.8 48.0/72.5 16.0/10.7 4.2/2.8 1.3
Sweet
Sweets “Ahlgrens bilar” (Cloetta, Sweden) 1450/350 6.0/6.8 0.3/0.8 81.0/92.4 55.0/62.7 0.25a
Sweets (gummies) “Gott&Blandat” (Malaco, Sweden) 1450/340 0.0/0 0.0/0 85.0/100 61.0/71.8 0.25a
Orange juice “Apelsin juice” (Kiviks Musteri AB, Sweden) 180/40 0.6/5.9 <0.5/11 8.5/83.1 8.5/83.1 0.01a
Sweet-and-fat
Milk chocolate “Marabou mjölkchoklad” (Marabou, Sweden) 2290/550 4.8/3.5 32.0/53 59.0/43.4 58.0/42.7 0.25a
Dark chocolate “Lindt Excellence 70% dark” (Lindt & Sprüngli, Sweden) 2180/520 8.0/6.1 40.0/68.7 33.0/25.2 28.0/21.4 0.15a
Chocolate covered toffee “Dumlekola original” (Fazer, Sweden) 1980/470 3.6/3.1 21.0/40.4 66.0/56.5 53.0/45.4 0.4a
Chocolate pastry “Delicatoboll” (Delicato, Sweden) 2000/480 5.0/4.2 29.0/54.7 49.0/41.1 30.0/25.2 0.4
Cinnamon bun “Kanelbulle” (Bonjour, VAASAN Sverige AB, Sweden) 1350/320 6.2/8 9.6/27.8 50/64.3 15/19.3 0.5
a Salt content initially expressed as sodium content has been converted to amount of salt by multiplying the sodium value by 2.5, as recommended by the Swedish Na-
tional Food Agency (Livsmedelsverket).
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decreased 38% between control and treated conditions (p < 0.001,
tAUC, Fig. 2D). Furthermore, there was a tendency toward a time
by treatment interaction inwanting sweet snacks, i.e. the time impact
on VAS-ratings depended on whether the participant received treat-
ment or placebo (F (11,231) = 1.803, p = 0.05). The urge for sweet
snacks was lower in the treated group compared to control at all
time points between breakfast and lunch, starting already at 15
minutes after breakfast. It was also lower in the afternoon at time
point 420 minutes (Fig. 2C).
Treatment with thylakoids also reduced ratings for wanting
sweet-and-fat snacks as shown in Fig. 2E (F (1,21) = 5.198, p < 0.05).
Wanting for sweet-and-fat decreased 36% in the treated group
compared to control (p < 0.05, tAUC, Fig. 2F). The urge for sweet-
and-fat snacks was lower in the treated group compared to control
at time points 60, 120, 180 minutes and also right before lunch at
285 minutes (Fig. 2E).
Similar to the effects on the separate categories of snacks re-
spectively, the ANOVA analysis of total wanting of all snacks revealed
an effect of treatment (F (1,21) = 7.364, p < 0.05, Fig. 2G). Subse-
quent analysis of individual time points showed that treatment
decreased total wanting at 15, 60, 120, 180, 285 and 420 minutes
after breakfast (p < 0.05). Wanting for all snacks combined de-
creased by 36% in the treated group compared to the control (p < 0.05,
tAUC, Fig. 2H).
Food intake from ad libitum snack buffet
Of the 22 participants, everyone ate something from the snack
buffet on both test days. Median total intake in the control group
was 912 kcal (lower and upper quartiles 619–1081 kcal) andmedian
intake in the thylakoid groupwas 810 kcal (lower and upper quartiles
598–1019 kcal), which corresponds to a reduced intake in the treated
condition by 11% (Fig. 3). This reduction, however, was not statis-
tically signiﬁcant.
There was a tendency toward a reduced caloric intake of salty
food items following treatment with thylakoids compared to control,
with a median difference of 65 kcal (p = 0.0547, Fig. 3). This corre-
sponds to a reduction in intake of salty snacks by 26% between
control and treated conditions, since median intake of salty snacks
in the control group was 248 kcal (lower and upper quartiles 111–
322 kcal) and median intake in the thylakoid group was 183 kcal
(lower and upper quartiles 80–294 kcal).
There were no signiﬁcant differences in the intake of sweet or
sweet-and-fat snacks between treatment and control conditions.
Liking for palatable food, measured after consumption from the
snack buffet
Only the participants who tasted an item were allowed to rate
their liking for it. For each speciﬁc food product to be included in
the analysis of liking scores, participants had to taste and rate their
liking for the product at both control and treatment days. One par-
ticipant was excluded from the analysis due to failure to ﬁll out the
form correctly. Treatment with thylakoids produced a lower liking
of sweet products after consumption, compared to control days
(p < 0.01, Fig. 4). Median rating for liking sweet was 32 in the control
group (lower and upper quartiles 21–52) and 23 in the thylakoid
group (lower and upper quartiles 9–40). This corresponds to a re-
duction in liking sweet by 28%. Median liking for all snacks together
was 27 in the control group (lower and upper quartiles 16–37) and
17 in the treated group (lower and upper quartiles 15–34). This
however was not signiﬁcant (p = 0.15, Fig. 4). Liking for salty and
sweet-and-fat products was not signiﬁcantly changed between treat-
ment and control days.
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Fig. 1. Hunger- and satiety-ratings following intake of thylakoids or placebo. Treatment with thylakoids decreased ratings of hunger (A, B) and increased ratings of satiety
(C, D) compared to the control. *p < 0.05, **p < 0.01. A and C: Two-way RM ANOVA followed by Wilcoxon signed rank test for individual time points. B and D: Wilcoxon
signed rank test.
213E.-L. Stenblom et al./Appetite 91 (2015) 209–219
Wanting salty snacks
0 60 120 180 240 300 360 420 480 540
0
10
20
30
40
 Time (min)
V
A
S
 (m
m
)
Control 
Treated
*** ** *
A
Breakfast 
08:00
Ø
Lunch 
13:00
Ø
Snacks 
16:00
Ø
Wanting sweet snacks
0 60 120 180 240 300 360 420 480 540
0
10
20
30
40
 Time (min)
V
A
S
 (m
m
)
Control 
Treated
*
** ** *
*
* *
C
Breakfast 
08:00
Ø
Lunch 
13:00
Ø
Snacks 
16:00
Ø
Wanting sweet-and-fat
0 60 120 180 240 300 360 420 480 540
0
10
20
30
40
 Time (min)
V
A
S
 (m
m
)
Control 
Treated
**
** **
*
E
Breakfast 
08:00
Ø
Lunch 
13:00
Ø
Snacks 
16:00
Ø
Total wanting all snacks
0 60 120 180 240 300 360 420 480 540
0
10
20
30
40
 Time (min)
V
A
S
 (m
m
)
Control 
Treated
*
*
***
*** **
*
G
Breakfast 
08:00
Ø
Lunch 
13:00
Ø
Snacks 
16:00
Ø
tAUC wanting salty snacks
Control Treated
0
50
100
150
200
V
A
S
 (m
m
) **
B
tAUC wanting sweet snacks
Control Treated
0
50
100
150
200
V
A
S
 (m
m
)
***
D
    tAUC wanting sweet-and-fat
Control Treated
0
50
100
150
200
V
A
S
 (m
m
)
*
F
tAUC wanting all snacks
Control Treated
0
50
100
150
200
V
A
S
 (m
m
)
*
H
Fig. 2. VAS-ratings of wanting salty, sweet, sweet-and-fat snacks and all snacks combined, comparing treatment and placebo conditions (control). Treatment with thyla-
koids reduced wanting for all categories of snacks compared to the control (A–H). Presented data are an average of the ratings for the individual items of palatable food,
presented per category (Table 3). For all parameters, effect of treatment was analyzed by tAUC and by two-way RM ANOVA followed by analysis of differences in individual
time points using Wilcoxon matched-pairs signed rank test. *p < 0.05, **p < 0.01, ***p < 0.001.
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Correlations between treatment effects on wanting versus treatment
effects on food intake
The treatment effect on wanting sweet-and-fat snacks was pos-
itively correlated with the treatment effect on intake of sweet-and-
fat snacks, so that greater reduction in wanting sweet-and-fat snacks
during the course of the day correlated with a reduced intake of
sweet-and-fat snacks at the ad libitum snack buffet in the after-
noon (p < 0.01, r = 0.54, Fig. 5A). Similarly, there was a positive
correlation between the treatment effect on wanting all kinds of
snacks and the treatment effect on intake of all kinds of snacks
(p < 0.01, r = 0.60, Fig. 5B). The correlation plots show that
participants with higher treatment effect on wanting, i.e. the great-
est reduction in ratings for wanting in the treated condition
compared to control, also have greatest reduction in food intake
between control and thylakoid trial days. There was also a posi-
tive correlation between the reduction in wanting sweet-and-fat and
the difference in total intake between control and treated condi-
tions (p < 0.01, r = 0.64).
Correlations between treatment effects on liking versus treatment
effects on food intake
The treatment effect on liking for sweet was positively corre-
lated with the treatment effect on intake of sweet, so that
participants with greatest reduction in intake of sweet snacks
between control and treated conditions rated lower liking for sweet
after consumption from the ad libitum snack buffet (p < 0.05, r = 0.58).
Similarly, there was a positive correlation between the treatment
effect on liking sweet-and-fat snacks and the treatment effect on
intake of sweet-and-fat snacks (p < 0.01, r = 0.58, Fig. 6A), liking all
kinds of snacks versus total snack intake (p < 0.01, r = 0.65, Fig. 6B),
liking all kinds of snacks versus intake of sweet-and-fat snacks
(p < 0.01, r = 0.57), and liking sweet-and-fat snacks versus total intake
of all snacks, control minus treated conditions (p < 0.01, r = 0.58).
Eating behavior measured by the three-factor eating questionnaire
(TFEQ-R18V2)
Participants responded to each of the 18 questions about state-
ments characterizing eating-related behaviors on a four-point Likert
scale (Likert, 1932). Responses were coded on a four-point scale (1–
4) with higher values indicating more of the behavior. Mean values
for each of the three behavioral categories were: emotional eating
domain 2.27 (+/− 0.15), cognitive restraint domain 2.52 (+/− 0.15)
and uncontrolled eating domain 2.26 (+/− 0.10).
Correlations between treatment effect on wanting and scores for
eating behavior
The treatment effect on wanting sweet-and-fat snacks as well
as all kinds of snacks was positively correlated with emotional eating
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Fig. 3. Energy intake from the afternoon snack buffet. Supplementation with thyla-
koids produced a tendency toward reduced caloric intake of salty snacks on treatment
day compared to control (p = 0.0547,Wilcoxonmatched-pairs signed rank test, n = 22).
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Fig. 4. Liking for speciﬁc food products after consumption, with and without treat-
ment with thylakoids. Liking of products (VAS) scored immediately after the ad libitum
snack buffet, presented in categories and as total liking for all products, divided by
the number of products in each category to produce an average score. Treatment
with thylakoids decreased the liking of sweet products between control and treat-
ment days (p < 0.05, Wilcoxon matched-pairs signed rank test, n = 18 for liking salt,
18 for sweet, 20 for sweet-and-fat, and 21 for total liking).
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Fig. 5. Correlations between treatment effects on wanting and treatment effects on food intake. Graphs show correlation plots of the treatment effect on VAS-ratings for
wanting sweet-and-fat snacks versus the treatment effect on intake of sweet-and-fat (A) and all kinds of snacks together (B). VAS-ratings and caloric intake are presented
as delta values, i.e. control day minus treatment day values in each category, the difference representing the treatment effect of thylakoids. The treatment effect on wanting
sweet-and-fat snacks was positively correlated to a reduction in food intake (p < 0.01, A), so was the treatment effect on all categories of snacks together (p < 0.01, B).
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scores, so that higher scores for emotional eating behavior was cor-
related to a greater treatment effect of thylakoids on ratings for
wanting sweet-and-fat foods (p < 0.01, r = 0.62, Fig. 7A) and all cat-
egories of palatable foods (p < 0.01, r = 0.55, Fig. 7B). Scores for
cognitive restraint and uncontrolled eating behavior were not cor-
related with treatment effects on wanting.
Additional correlations analyzed
There were no statistically signiﬁcant correlations between the
different eating behavior scores and the treatment effect of thyla-
koids on hunger, satiety, food intake or liking. Neither were there
any correlations between BMI or body fat percentage and scores for
eating behavior, nor any correlations between the different eating
behavior scores.
No serious adverse events or effects were reported. Mild cases
of nausea during or after the snack buffet occurred at three occa-
sions in the placebo group and at two occasions in the treated group.
Headaches were reported at two occasions in the placebo group and
at one occasion in the treated group.
Discussion
The present study demonstrates that a single dose of thyla-
koids prior to breakfast increased subjective ratings of satiety and
decreased ratings of hunger as well as cravings for snacks and sweets
during the day. Intake of thylakoids also decreased subjective liking
for sweet, scored directly following consumption. There are strong
correlations between the treatment effect on wanting and actual
food intake between control and thylakoid conditions, as well as
between the treatment effect on liking and food intake, even though
there were no signiﬁcant differences in food intake per se. When
correlated to eating behavior scores, treatment effect of thyla-
koids on wanting was positively correlated to emotional eating for
all snacks, sweet-and-fat foods being speciﬁcally targeted.
The promotion of satiety by thylakoids found in this study is an
entirely novel ﬁnding. This started 60 minutes after breakfast, sug-
gesting enhanced early satiety signaling. In addition, ratings for
satiety in the treated group were also higher several hours after
lunch, compared to placebo. Both the acute and late effects of thyla-
koids to enhance satiety may be explained by increased secretion
of satiety hormones CCK and GLP-1 (Köhnke, Lindbo et al., 2009;
Montelius et al., 2014; Stenblom et al., 2013).
Both CCK and GLP-1 are known to have a biphasic pattern of se-
cretion. Through gastric distension, as well as by calories entering
the small intestine, CCK is released, ﬁrst in the hypothalamus, and
later peripherally, which induces satiety (Pappas, 1992). GLP-1 se-
cretion has a similar pattern, the early phase being mediated by the
vagus nerve and the second phase by direct contact of luminal nu-
trients with the L-cells in the distal small intestine (Baggio & Drucker,
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Fig. 6. Correlations between treatment effects on liking and treatment effects on food intake. Graphs show correlation plots of the treatment effect on VAS-ratings for liking
sweet-and-fat (A), and all snacks (B), versus treatment effect on intake of the corresponding categories of snacks. VAS-ratings and caloric intake are presented as delta values,
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Fig. 7. Correlation between treatment effect of thylakoids on wanting palatable food and emotional eating behavior scores. Graphs show correlation plots of the treatment
effect on VAS-ratings for wanting versus scores for emotional eating measured by the TFEQR18-V2 (A and B). VAS-ratings are presented as delta values, i.e. control day
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2007; Flint, Raben, Ersbøll, Holst, & Astrup, 2001; Näslund &
Hellström, 2007; Wishart, Horowitz, Morris, Jones, & Nauck, 1998).
Treatment also had an attenuating effect on hunger ratings
throughout the day. In comparison to ratings for satiety, the dif-
ference in hunger ratings reached signiﬁcance later, at 180 minutes
after breakfast in comparison to 60 minutes for satiety. The present
ﬁndings on hunger verify previous reports on decreased hunger
ratings following treatment with thylakoids (Stenblom et al., 2013,
2014). The suppressed hunger may both be related to reduced
ghrelin-levels (Köhnke, Lindbo et al., 2009) and an indirect effect
of increased circulating levels of the satiety hormones CCK and
GLP-1. Indeed, the late appearance of hunger suppression sug-
gests an indirect effect by thylakoids on promotion of satiety
hormones. GLP-1 in physiological levels has been shown to inhibit
gastric emptying and reduce ratings of hunger (Flint et al., 2001).
A reduction in ghrelin levels would cause a similar effect, since
ghrelin accelerates gastric emptying and stimulates eating
(Cummings, Frayo, Marmonier, Aubert, & Chapelot, 2004).
Besides increasing satiety and reducing hunger, in this study,
treatment with thylakoids also reduced wanting for all categories
of palatable snacks: salty, sweet, sweet-and-fat and all snacks to-
gether, compared to control. This is a novel ﬁnding. In comparison,
decreased urge for sweet and sweet-and-fat foods has previously
been reported in long-term studies (Montelius et al., 2014; Stenblom
et al., 2014), but never in a single dose meal study using within-
subject comparisons, which is more sensitive and accurate in
measuring appetite scores (Flint et al., 2000). Interestingly, in the
three-month study (Montelius et al., 2014), on the ﬁrst day of treat-
ment, ratings for wanting sweets and wanting chocolate were
signiﬁcantly lower in the treated group compared to control in the
afternoon. In contrast, in the present study, treatment suppressed
wanting for sweets and snacks already before lunch and this effect
lasted throughout the day. The difference between the two studies
lies in the experimental setting. In the three-month study, partici-
pants stayed in the laboratory for blood sampling between breakfast
and lunch. During this time, they did not score high for wanting.
In the afternoon however, in their natural environment, the control
group scored higher, and the differences in wanting appeared. In
the present study, participants went back to their everyday cir-
cumstances between breakfast and lunch. Consequently, they were
exposed to food cues such as colleagues having coffee and cake at
the midmorning break. In comparison, on day 90 of the three-
month study, cravings for sweets and chocolate were signiﬁcantly
lower both before lunch and after lunch in the treated group, showing
the potentiation of the effect due to the repeated administration of
thylakoids on wanting.
The present results demonstrate that treatment with thyla-
koids have immediate effects on wanting. This may be an effect of
altered levels of appetite regulating hormones, since both GLP-1 and
ghrelin have been implicated in food reward (Egecioglu et al., 2010;
Skibicka, 2013; Skibicka, Hansson, Egecioglu, & Dickson, 2012).
The suggested mechanism, according to previous studies in
humans, may be the increased release of GLP-1 following thyla-
koid supplementation (Montelius et al., 2014). GLP-1 analogs have
been shown to decrease the rewarding value of sweet (sucrose) and
sweet-and-fat (chocolate) food, decrease food intake and shift food
preference from candy to chow in rat (Dickson, Shirazi, Hansson,
Bergquist, & Nissbrandt, 2012; Raun et al., 2007).
In the present study, participants who scored higher for emo-
tional eating behavior experienced greater effect of thylakoids on
reducingwanting for palatable food, particularly sweet-and-fat foods.
Emotional eating behavior is associated with increased consump-
tion of sweet-and-fat foods, especially in response to stressors and
negative emotions (Cappelleri et al., 2009; Epel, Lapidus, McEwen,
& Brownell, 2001; Keskitalo et al., 2008). Therefore, the partici-
pants in this study scoring high for emotional eating behavior were
more susceptible to the effects of thylakoids to reduce the reward-
ing properties of sweet-and-fat foods. Since the correlation between
eating behavior types and BMI is strongest for emotional eating be-
havior, it is important to target overeating in emotional eaters
speciﬁcally to avoid weight gain in this group (Karlsson, Persson,
Sjöström, & Sullivan, 2000).
Measuring food intake is diﬃcult due to the complex nature of
eating behavior (Blundell et al., 2010). Accordingly, despite the in-
creased satiety and decreased hunger and wanting during the day,
food intake was not signiﬁcantly affected in the experimental setting
of the present study. There was however a tendency toward de-
creased intake of salty snacks by treatment, which is a new ﬁnding.
Measuring food intake alone is not reliable, since measurement of
food is constrained by the experimental design. Instead, food intake
is best used in conjunction with measurements of motivation to eat
(Stubbs et al., 2000). Visual analog scales (VAS) are reliable tools
for this assessment (Drapeau et al., 2007; Flint et al., 2000). In the
present study, correlation analyses showed that treatment effects
on VAS-scores for wanting and liking correlated positively with a
reduction in food intake between control and thylakoid condi-
tions. These ﬁndings indicate that individuals who experience the
greatest reduction of VAS-ratings for wanting and liking also have
the greatest reduction in food intake of the corresponding prod-
ucts. Though measurements of consumption of the foods tested did
not show statistically signiﬁcant differences between treated and
controls in this single dose study design, the correlation analyses
reveals treatment effects of thylakoids that are likely to inﬂuence
food consumption in repeated dose situations as shown in a pre-
vious three-month study with daily supplementation of thylakoids
(Montelius et al., 2014). Thus, ratings of wanting may be more ac-
curate in predicting eating behavior in a real-life situation compared
to food intake alone. This emphasizes the importance of the re-
ported ﬁndings that thylakoids suppress hunger and wanting.
However, although we demonstrated a depressed hunger and
wanting by thylakoids in this study we cannot assure that this guar-
antees a decreased food intake.
After the afternoon snack buffet, ratings of liking for sweet food
were suppressed in the treated group compared to placebo. Liking
is generally considered to be related to opioid signaling (Berridge,
2009). The preference for sweet taste is regulated by endogenous
opiates (endorphins), which are also implicated in food cravings and
drug reward. Consistently, opiate antagonists have been shown to
reduce rated pleasure for sweet (Fantino, Hosotte, & Apfelbaum,
1986; Yoshida et al., 2010). Enterostatin, released during fat diges-
tion, acts like an opioid antagonist in animal models, in particular
when the fat digestion is retarded (Berger, Winzell, Mei, &
Erlanson-Albertsson, 2004; Ookuma, Barton, York, & Bray, 1997;
Takenaka et al., 2008). Consequently, one could argue that thyla-
koids through its retardation of fat digestion, as previously
demonstrated (Albertsson et al., 2007), may cause an increased
release of enterostatin and thus induce an opiate-blocking effect,
which affects liking for sweet in this study. Leptin has also been dem-
onstrated to stop the liking of sweet food (Yoshida et al., 2010). In
a previous publication (Köhnke, Lindbo et al., 2009), there was an
increased release of leptin at time point 360 min after intake of
breakfast with thylakoids compared to control. Consequently, leptin
may also assist in the suppression of liking sweet caused by
thylakoids.
Findings on reduced liking are important. Indeed, overweight
women have been shown to have an increased liking for sweet
(Ettinger, Duizer, & Caldwell, 2012). Furthermore, liking of sweet-
ness inﬂuences wanting of sweet-tasting products (Drewnowski,
Mennella, Johnson, & Bellisle, 2012). Thus, a reduced likingmay, over
time, cause a reduction in wanting for sweet. As a consequence,
this may reduce snacking in between meals and hence overeating.
In this study, besides reducing liking for sweet after consumption,
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treatment reduced wanting for sweet to a greater extent com-
pared to other kinds of snacks. There was also an earlier onset;
wanting for sweet was reduced from 15 minutes following break-
fast and onwards, in comparison to wanting for salty and sweet-
and-fat snacks, which were reduced from 60 minutes respectively.
This implies that treatment with thylakoids has a particular effect
on liking and wanting sweet. The mechanism for this targeting is
not known. Further studies are needed to understand the effects of
thylakoids to suppress the liking for sweet taste, diminish the urge
for palatable food and its particular effect in emotional eaters, in-
cluding measurement of gut hormones.
Conclusion
Supplementation with thylakoids in the morning affects sub-
jective ratings of appetite during the rest of the day. It reduces
feelings of hunger and increases feelings of satiety. It also reduces
wanting for palatable food, and this effect is enhanced in emotion-
al eaters. Furthermore, the treatment effect on wanting and liking
is correlated to reduction in food intake. In addition, liking for sweet
is reduced after consumption. We suggest that these effects are due
to altered secretion of appetite regulating hormones, induced by the
thylakoids, affecting reward-related areas in the brain.
Even though analysis of appetite regulating hormones could have
made our study stronger, we deliberately did not take any blood
samples in this study. Since laboratory settings have been shown
to interfere with thoughts about food and food intake, a natural sur-
rounding was preferred in order to achieve more accurate results
on VAS-ratings and food consumption (Blundell et al., 2010). Another
possible limitation to this study was the small number of partici-
pants even though the cross over design increased the power.
With these limitations in mind, we have shown that treatment
with thylakoids attenuate hunger, homeostatic and hedonic, in-
cluding wanting for palatable food and liking for sweet. Reducing
wanting is important, since wanting is a major cause of hedonic
eating, which contributes to overconsumption and obesity (Blundell
& Gillett, 2001; Koenders & van Strien, 2011; Yeomans et al., 2004).
In addition, individuals who are obese and/or dieting are even more
susceptible to hedonic hunger (Garber & Lustig, 2011). Therefore,
reducing cravings for palatable food is necessary, both to control
appetite, prevent weight gain and to facilitate a permanent
weight loss. Supplementation by thylakoids may help prevent
eating betweenmeals, hence over-eating and in the long run, weight
gain.
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